Kronos Adv Tech Stock Price, News & Analysis

KronosMD, a subsidiary of Kronos Advanced Technologies (OTC: KNOS), has acquired all assets and intellectual property related to its innovative 3D ultrasound dental imaging devices. This acquisition aims to boost the commercialization of the S-WAVE™ platform, which is nearing completion. The 3D ultrasound-powered S-WAVE SCAN™ is positioned to transform dental imaging by providing radiation-free diagnostics, enhancing safety and accuracy for patients. With a projected ultrasound devices market size of $9.1 billion by 2027, the strategic importance of this acquisition is evident as it positions KronosMD to lead in a rapidly evolving market.

KronosMD (OTC: KNOS) announced that CEO Dr. Greg Rubin will attend the Roth Investor Conference on March 13-14, 2023, to engage with investors, investment bankers, and industry leaders. Attendees can schedule meetings with Dr. Rubin to discuss capital provisions and learn about KronosMD's innovative digital health technology, including the transformative SWAVE™ ultrasound imaging for dental care. This conference is a significant platform for small-cap companies, offering networking and insights into investment opportunities across various sectors.

Investors seeking further details can reach out via KronosMD's investor relations.

Kronos Advanced Technologies, Inc. (OTC: KNOS) announced new research linking air pollution to bone damage in women with osteoporosis, highlighting elevated air pollutants' impact on lumbar spine bone density. The study, conducted by Columbia University's Mailman School of Public Health, analyzed data from 161,808 postmenopausal women and found that nitrogen oxides significantly contribute to bone damage.

In related news, Kronos' air disinfection technology has received FDA 510(k) clearance, proving effective against harmful airborne particles. This positions Kronos' products as viable solutions in healthcare and other industries, enhancing indoor air quality and offering substantial long-term cost savings.

The FDA has granted 510(k) clearance to Kronos Advanced Technologies' Model 5 air purifier, classifying it as a Class II Medical Device. This technology, which eliminates 99.9% of harmful airborne particles, including viruses and allergens, allows for deployment in healthcare settings. The device's patented High Voltage Field technology and washable filters provide significant market advantages over traditional HEPA systems. Kronos aims to leverage this certification to expand its market presence across various sectors, including hospitals and schools, while ensuring compliance with California's CARB regulations.

Kronos Advanced Technologies, Inc. (KNOS) announced an extended Black Friday sale starting November 22, 2022, featuring deep discounts on its air purifiers and graphene face masks. Discounts include $100 off select models, $250 off Model 8, and 60% off popular car air purifiers. Kronos’s patented filter-less technology claims to outperform traditional HEPA filters by efficiently destroying harmful particles. Their products are noted for being virtually silent and cost-effective, with ongoing research supporting their air purification effectiveness.

KronosMD Inc. has been established as a new medical manufacturing subsidiary of Kronos Advanced Technologies (OTC: KNOS), focusing on advanced healthcare manufacturing and technology acquisition in the Medical Devices market. This initiative aligns with Kronos' 2022 growth strategy, enhancing its diversification efforts. The U.S. medical device market, valued at $176.7 billion in 2020, is projected to grow at a CAGR of 5.0%. KronosMD aims to leverage existing resources to provide innovative solutions, including potential collaborations with companies in the medical imaging field.

Kronos Advanced Technologies (OTC: KNOS) has completed the acquisition of an 85,000 sq. ft. manufacturing campus in Parkersburg, WV for $5.8 million. The facility, previously used for advanced electronics, will be adapted to produce air purification devices. This strategic move aims to transition Kronos from a marketing-centric company to a globally recognized manufacturer. The new site is expected to create approximately 300 jobs by June 2022, enhancing operational efficiency and positioning Kronos to leverage local demographics, benefiting from state economic incentives for job creation and investment.

Kronos Advanced Technologies (OTC: KNOS) has announced the exclusive national distribution of the ViralWall™ device, which utilizes a patented graphene-based air filter to kill pathogens in exhaled air. This self-sterilizing air purifier, developed by LIGC Application LTD, targets bacteria and viruses, including antibiotic-resistant strains. The technology, born from a collaboration between Rice University and Ben-Gurion University, showcases the potential of graphene to enhance air purification. Kronos aims to produce affordable, energy-efficient products while addressing indoor air quality concerns.

Kronos Advanced Technologies (OTC: KNOS) has announced the filing of a trademark for its brand to be utilized in the Metaverse. Joining industry giants like Meta and Nike, Kronos aims to establish a virtual commerce presence. Bloomberg Intelligence projects the Metaverse market could reach $800 billion by 2024, with opportunities in gaming and live events. CEO Michael Rubinov expressed optimism about securing competitive advantages through these digital assets, with further trademark filings planned for the future.